アルツハイマー病のアジアコホート（ACAD）研究プロトコル
Pei-Chuan Ho1,2, Guerry M Peavy3, Haeok Lee4
1Department of Pathology and Laboratory Medicine Penn Neurodegeneration Genomics Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
Alzheimer's & dementia (New York, N. Y.)
|December 24, 2025
まとめ
アルツハイマー病のアジアコホート（ACAD）研究は、アルツハイマー病（AD）の遺伝的および非遺伝的危険因子を特定するために、多様なアジア系集団を募集しています。この研究は、過小評価されているコミュニティのADの診断と治療を改善することを目的としています。
さらに関連する動画
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.3K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.3K
関連する概念動画
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744